Lates News

AstraZeneca (AZN.US): Q3 2025 financial report achieved revenue of $15.191 billion, previous value was $13.565 billion, and the expected value was $14.8052 billion; Earnings per share were $1.19, the previous value was $1.04, and the expected value was $1.14.